{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:27:11Z","timestamp":1794853631730,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014477","name":"National Health Insurance Administration","doi-asserted-by":"publisher","award":["NHRI-EX97-9741PI"],"award-info":[{"award-number":["NHRI-EX97-9741PI"]}],"id":[{"id":"10.13039\/100014477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-038-089"],"award-info":[{"award-number":["NSTC 113-2314-B-038-089"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST110-2314-B-038-072-MY3"],"award-info":[{"award-number":["MOST110-2314-B-038-072-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST111-2314-B-038-065-MY3"],"award-info":[{"award-number":["MOST111-2314-B-038-065-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Taipei Municipal Wan-Fang Hospital","doi-asserted-by":"publisher","award":["113-wf-eva-18"],"award-info":[{"award-number":["113-wf-eva-18"]}],"id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Taipei Municipal Wan-Fang Hospital","doi-asserted-by":"publisher","award":["112-wf-eva-31"],"award-info":[{"award-number":["112-wf-eva-31"]}],"id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Taipei Municipal Wan-Fang Hospital","doi-asserted-by":"publisher","award":["113TMU-WFH-07"],"award-info":[{"award-number":["113TMU-WFH-07"]}],"id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Taipei Municipal Wan-Fang Hospital","doi-asserted-by":"publisher","award":["111TMU-WFH-14"],"award-info":[{"award-number":["111TMU-WFH-14"]}],"id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpsychires.2025.02.052","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:03:28Z","timestamp":1740701008000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inverse dose-dependent effects of aripiprazole on sexual dysfunction and prolactin levels in patients with schizophrenia"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-6248","authenticated-orcid":false,"given":"Tzu-Hua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2677-3944","authenticated-orcid":false,"given":"Kah Kheng","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-8174","authenticated-orcid":false,"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-8193","authenticated-orcid":false,"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jpsychires.2025.02.052_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1389","article-title":"Neuroanatomy and function of human sexual behavior: a neglected or unknown issue?","volume":"9","author":"Calabro","year":"2019","journal-title":"Brain Behav"},{"issue":"7","key":"10.1016\/j.jpsychires.2025.02.052_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/11533140-000000000-00000","article-title":"Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management","volume":"24","author":"Coker","year":"2010","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.052_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.052_bib5","first-page":"74","article-title":"Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study","volume":"50","author":"Fujioi","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.02.052_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expet Opin. Pharmacother."},{"issue":"22","key":"10.1016\/j.jpsychires.2025.02.052_bib7","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00213-017-4730-6","article-title":"Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research","volume":"234","author":"Grigg","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2478\/acph-2014-0036","article-title":"Therapeutic drug monitoring of atypical antipsychotic drugs","volume":"64","author":"Grundmann","year":"2014","journal-title":"Acta Pharm."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41537-021-00170-3","article-title":"Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study","volume":"7","author":"Hoekstra","year":"2021","journal-title":"NPJ Schizophr"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12888-020-02957-7","article-title":"Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?","volume":"20","author":"Jen","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YIC.0b013e328351c8c4","article-title":"Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study","volume":"27","author":"Jeong","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/686924","article-title":"Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: a cross-sectional study","volume":"2011","author":"Johnsen","year":"2011","journal-title":"Adv Urol"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.052_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114030","article-title":"Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil","volume":"302","author":"Kelly","year":"2021","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jsm.12246","article-title":"Remitted male schizophrenia patients with sexual dysfunction","volume":"11","author":"Kheng Yee","year":"2014","journal-title":"J. Sex. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pnpbp.2011.11.016","article-title":"Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics","volume":"37","author":"Kikuchi","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00406-018-0975-2","article-title":"Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure","volume":"270","author":"Kiss","year":"2020","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bcpt.13323","article-title":"Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers","volume":"126","author":"Koller","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib19","article-title":"Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia: a post-hoc analysis of the real-world data of a multicenter study","volume":"15","author":"Li","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/cap.2022.0068","article-title":"Relationship between plasma aripiprazole and dehydroaripiprazole concentrations and prolactin levels in Chinese children and adolescents","volume":"33","author":"Ma","year":"2023","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.052_bib21","first-page":"217","article-title":"Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin","volume":"46","author":"Martin","year":"2018","journal-title":"Actas Esp. Psiquiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona sexual experience scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J. Sex Marital Ther."},{"issue":"11","key":"10.1016\/j.jpsychires.2025.02.052_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.57.11.1012","article-title":"The neurobiology of sexual function","volume":"57","author":"Meston","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0269881107082901","article-title":"Change in sexual dysfunction with aripiprazole: a switching or add-on study","volume":"22","author":"Mir","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.052_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1819.2012.02391.x","article-title":"Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia","volume":"66","author":"Nagai","year":"2012","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1464-410X.2005.05348.x","article-title":"Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries","volume":"95","author":"Nicolosi","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2021.08.022","article-title":"Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medications","volume":"143","author":"Redman","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-013-0129-4","article-title":"Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis","volume":"37","author":"Reichenpfader","year":"2014","journal-title":"Drug Saf."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.02.052_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00228-018-2498-1","article-title":"Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews","volume":"74","author":"Ribeiro","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.052_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031305","article-title":"Prolactin secretion in healthy adults is determined by gender, age and body mass index","volume":"7","author":"Roelfsema","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.052_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/JCP.0000000000000539","article-title":"How hyperprolactinemia affects sexual function in patients under antipsychotic treatment","volume":"36","author":"Rubio-Abadal","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/cap.2012.0062","article-title":"Prolactin serum concentrations during aripiprazole treatment in youth","volume":"23","author":"Safer","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis","volume":"29","author":"Serretti","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2016.08.022","article-title":"Sexual dysfunction among women with Schizophrenia-A cross sectional study from India","volume":"24","author":"Simiyon","year":"2016","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCP.0000000000000527","article-title":"Aripiprazole-associated hypoprolactinemia in the clinical setting","volume":"36","author":"Sogawa","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.02.052_bib37","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update","volume":"30","author":"Spina","year":"2008","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.052_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11594710-000000000-00000","article-title":"Clinically significant drug interactions with newer antidepressants","volume":"26","author":"Spina","year":"2012","journal-title":"CNS Drugs"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2025.02.052_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.12.027","article-title":"Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics","volume":"145","author":"Suzuki","year":"2013","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.052_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FTD.0000000000000843","article-title":"Relationship of prolactin concentrations to steady-state plasma concentrations of aripiprazole in schizophrenia patients","volume":"43","author":"Tasaki","year":"2021","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/npr2.12190","article-title":"Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels","volume":"41","author":"Tasaki","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.052_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jsxm.2020.12.007","article-title":"The impact of psychosis on sexual functioning: a systematic review","volume":"18","author":"Vargas-C\u00e1ceres","year":"2021","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.052_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/JCP.0b013e31820e4832","article-title":"Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion","volume":"31","author":"Veselinovic","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.052_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/FTD.0b013e3181956726","article-title":"Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole","volume":"31","author":"Waade","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib45","article-title":"The relationships between hyperprolactinemia, metabolic disturbance, and sexual dysfunction in patients with schizophrenia under olanzapine treatment","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib46","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.12659\/MSM.913759","article-title":"Prolactin and thyroid stimulating hormone (tsh) levels and sexual dysfunction in patients with schizophrenia treated with conventional antipsychotic medication: a cross-sectional study","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jpsychires.2025.02.052_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:14:50Z","timestamp":1751382890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"alternative-id":["S0022395625001311"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.02.052","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inverse dose-dependent effects of aripiprazole on sexual dysfunction and prolactin levels in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}